Bruton's tyrosine kinase is required for TLR-induced IL-10 production

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 7203-7210

  Schmidt, Nathan W ^a   Thieu, Vivian T ^a   Mann, Brandon A ^a   Ahyi, Ayele Nati N ^a   Kaplan, Mark H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIGAND; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DISEASE MODEL; ENDOTOXEMIA; ENZYME ACTIVATION; ENZYME ACTIVITY; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DNA BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN; X LINKED AGAMMAGLOBULINEMIA;

EID: 33750840753     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.7203     Document Type: Article

References (45)

1. Satterthwaite, A. B., and O. N. Witte. 2000. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol. Rev. 175: 120-127.
2. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A. B. Kantor, L. A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3: 283-299.
3. Horwood, N. J., T. Mahon, J. P. McDaid, J. Campbell, H. Mano, F. M. Brennan, D. Webster, and B. M. Foxwell. 2003. Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor-α production. J. Exp. Med. 197: 1603-1611.
4. Jefferies, C. A., S. Doyle, C. Brunner, A. Dunne, E. Brint, C. Wietek, E. Walch, T. Wirth, and L. A. O'Neill. 2003. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor κB activation by Toll-like receptor 4. J. Biol. Chem. 278: 26258-26264.
5. Gray, P., A. Dunne, C. Brikos, C. A. Jefferies, S. L. Doyle, and A. O'Neill L. 2006. MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. J. Biol. Chem. 281: 10489-10495.
6. Mansell, A., R. Smith, S. L. Doyle, P. Gray, J. E. Fenner, P. J. Crack, S. E. Nicholson, D. J. Hilton, L. A. O'Neill, and P. J. Hertzog. 2006. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7: 148-155.
7. Doyle, S. L., C. A. Jefferies, and L. A. O'Neill. 2005. Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFκB activation by lipopolysaccharide. J. Biol. Chem. 280: 23496-23501.
8. Mukhopadhyay, S., M. Mohanty, A. Mangla, A. George, V. Bal, S. Rath, and B. Ravindran. 2002. Macrophage effector functions controlled by Bruton's tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance. J. Immunol. 168: 2914-2921.
9. Horwood, N. J., T. H. Page, J. P. McDaid, C. D. Palmer, J. Campbell, T. Mahon, F. M. Brennan, D. Webster, and B. M. Foxwell. 2006. Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J. Immunol. 176: 3635-3641.
10. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350: 423-426.
11. Toney, L. M., G. Cattoretti, J. A. Graf, T. Merghoub, P. P. Pandolfi, R. Dalla-Favera, B. H. Ye, and A. L. Dent. 2000. BCL-6 regulates chemokine gene transcription in macrophages. Nat. Immunol. 1: 214-220.
12. Schmidt, N. W., L. D. Mayo, D. B. Donner, and M. H. Kaplan. 2006. p53 regulates Btk-dependent B cell proliferation but not differentiation. J. Leukocyte Biol. 79: 852-859.
13. Kawakami, Y., N. Inagaki, S. Salek-Ardakani, J. Kitaura, H. Tanaka, K. Nagao, Y. Kawakami, W. Xiao, H. Nagai, M. Croft, and T. Kawakami. 2006. Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3. Proc. Natl. Acad. Sci. USA 103: 153-158.
14. Sun, H., C. H. Charles, L. F. Lau, and N. K. Tonks. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487-493.
15. Slack, D. N., O. M. Seternes, M. Gabrielsen, and S. M. Keyse. 2001. Distinct binding determinants for ERK2/p38α and JNK map kinases mediate catalytic activation and substrate selectivity of MAP kinase phosphatase-1. J. Biol. Chem. 276: 16491-16500.
16. Chi, H., S. P. Barry, R. J. Roth, J. J. Wu, E. A. Jones, A. M. Bennett, and R. A. Flavell. 2006. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. USA 103: 2274-2279.
17. Salojin, K. V., I. B. Owusu, K. A. Millerchip, M. Potter, K. A. Platt, and T. Oravecz. 2006. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176: 1899-1907.
18. Zhao, Q., X. Wang, L. D. Nelin, Y. Yao, R. Matta, M. E. Manson, R. S. Baliga, X. Meng, C. V. Smith, J. A. Bauer, et al. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203: 131-140.
19. Chen, P., J. Li, J. Barnes, G. C. Kokkonen, J. C. Lee, and Y. Liu. 2002. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 169: 6408-6416.
20. Shepherd, E. G., Q. Zhao, S. E. Welty, T. N. Hansen, C. V. Smith, and Y. Liu. 2004. The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J. Biol. Chem. 279: 54023-54031.
21. Zhao, Q., E. G. Shepherd, M. E. Manson, L. D. Nelin, A. Sorokin, and Y. Liu. 2005. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J. Biol. Chem. 280: 8101-8108.
22. -/- mice: insufficient counter regulation of a Th1 response. Int. Rev. Immunol. 19: 91-121.
23. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
24. Kullberg, M. C., J. M. Ward, P. L. Gorelick, P. Caspar, S. Hieny, A. Cheever, D. Jankovic, and A. Sher. 1998. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and γ-interferon-dependent mechanism. Infect. Immun. 66: 5157-5166.
25. Dai, W. J., G. Kohler, and F. Brombacher. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158: 2259-2267.
26. Hasko, G., L. Virag, G. Egnaczyk, A. L. Salzman, and C. Szabo. 1998. The crucial role of IL-10 in the suppression of the immunological response in mice exposed to staphylococcal enterotoxin B. Eur. J. Immunol. 28: 1417-1425.
27. Reid, R. R., A. P. Prodeus, W. Khan, T. Hsu, F. S. Rosen, and M. C. Carroll. 1997. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J. Immunol. 159: 970-975.
28. Horng, T., G. M. Barton, R. A. Flavell, and R. Medzhitov. 2002. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420: 329-333.
29. Yamamoto, M., S. Sato, H. Hemmi, H. Sanjo, S. Uematsu, T. Kaisho, K. Hoshino, O. Takeuchi, M. Kobayashi, T. Fujita, et al. 2002. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420: 324-329.
30. Shinohara, H., A. Inoue, N. Toyama-Sorimachi, Y. Nagai, T. Yasuda, H. Suzuki, R. Horai, Y. Iwakura, T. Yamamoto, H. Karasuyama, et al. 2005. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. J. Exp. Med. 201: 333-339.
31. Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6: 777-784.
32. Hacker, H., V. Redecke, B. Blagoev, I. Kratchmarova, L. C. Hsu, G. G. Wang, M. P. Kamps, E. Raz, H. Wagner, G. Hacker, et al. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439: 204-207.
33. Saraiva, M., J. R. Christensen, A. V. Tsytsykova, A. E. Goldfeld, S. C. Ley, D. Kioussis, and A. O'Garra. 2005. Identification of a macrophage-specific chromatin signature in the IL-10 locus. J. Immunol. 175: 1041-1046.
34. Wang, Z. Y., H. Sato, S. Kusam, S. Sehra, L. M. Toney, and A. L. Dent. 2005. Regulation of IL-10 gene expression in Th2 cells by Jun proteins. J. Immunol. 174: 2098-2105.
35. Popi, A. F., J. D. Lopes, and M. Mariano. 2004. Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro. Immunology 113: 348-354.
36. Junqueira-Kipnis, A. P., A. Kipnis, M. Henao Tamayo, M. Harton, M. Gonzalez Juarrero, R. J. Basaraba, and I. M. Orme. 2005. Interleukin-10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosis. Immunology 115: 246-252.
37. + B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 22: 467-477.
38. Driessler, F., K. Venstrom, R. Sabat, K. Asadullah, and A. J. Schottelius. 2004. Molecular mechanisms of interleukin-10-mediated inhibition of NF-κB activity: a role for p50. Clin. Exp. Immunol. 135: 64-73.
39. Williams, L., L. Bradley, A. Smith, and B. Foxwell. 2004. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 172: 567-576.
40. Perez de Diego, R., E. Lopez-Granados, M. Pozo, C. Rodriguez, P. Sabina, A. Ferreira, G. Fontan, M. C. Garcia-Rodriguez, and S. Alemany. 2006. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes. J. Allergy Clin. Immunol. 117: 1462-1469.
41. Yao, Y., W. Li, M. H. Kaplan, and C. H. Chang. 2005. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J. Exp. Med. 201: 1899-1903.
42. Amedei, A., C. Romagnani, M. Benagiano, A. Azzurri, F. Fomia, F. Torrente, A. Plebani, M. M. D'Elios, and G. Del Prete. 2001. Preferential Th1 profile of T helper cell responses in X-linked (Bruton's) agammaglobulinemia. Eur. J. Immunol. 31: 1927-1934.
43. Farrar, J. E., I. Rohrer, and M. E. Conley. 1996. Neutropenia in X-linked agammaglobulinemia. Clin. Immunol. Immunopathol. 81: 271-276.
44. Plebani, A., A. Soresina, R. Rondelli, G. M. Amato, C. Azzari, F. Cardinale, G. Cazzola, R. Consolini, D. De Mattia, G. Dell'Erba, et al. 2002. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin. Immunol. 104: 221-230.
45. Kanegane, H., H. Taneichi, K. Nomura, T. Futatani, and T. Miyawaki. 2005. Severe neutropenia in Japanese patients with X-linked agammaglobulinemia. J. Clin. Immunol. 25: 491-495.